人类布鲁氏菌病不同治疗方案的早期临床反应

Early clinical response to different therapeutic regimens for human brucellosis.

作者信息

Malik G M

机构信息

College of Medicine, King Saud University, Abha Branch, Saudi Arabia.

出版信息

Am J Trop Med Hyg. 1998 Feb;58(2):190-1. doi: 10.4269/ajtmh.1998.58.190.

DOI:10.4269/ajtmh.1998.58.190

PMID:9502602

Abstract

Seventy-three cases of acute brucellosis were studied in relation to fever duration and hospital stay following different drug combinations, including gentamicin plus cotrimoxazole, rifampicin plus doxycycline, rifampicin plus cotrimoxazole, rifampicin plus tetracycline, streptomycin plus doxycycline, doxycycline plus cotrimoxazole, tetracycline plus cotrimoxazole, and tetracycline plus streptomycin. No statistical significant difference was found between these combinations regarding early clinical response in human brucellosis.

摘要

对73例急性布鲁氏菌病患者进行了研究，观察不同药物组合（包括庆大霉素加复方新诺明、利福平加多西环素、利福平加复方新诺明、利福平加四环素、链霉素加多西环素、多西环素加复方新诺明、四环素加复方新诺明以及四环素加链霉素）治疗后的发热持续时间和住院时间。在人类布鲁氏菌病的早期临床反应方面，这些组合之间未发现统计学上的显著差异。